Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice

Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice

Show other versions (1)
Bibliographic Details
Main Authors: Fabien Calcagno, Sabrina Lenoble, Zaher Lakkis, Thierry Nguyen, Samuel Limat, Christophe Borg, Marine Jary, Stefano Kim, Virginie Nerich
Format: Article
Language:English
Published: SAGE Publishing 2016-07-01
Series:Clinical Medicine Insights: Oncology
Online Access:http://www.la-press.com/efficacy-safety-and-cost-of-regorafenib-in-patients-with-metastatic-co-article-a5743
id doaj-4d40783b7b7d481485ea32e0c8ca7816
record_format Article
spelling doaj-4d40783b7b7d481485ea32e0c8ca78162020-11-25T03:55:07ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492016-07-0120161059665743Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical PracticeFabien CalcagnoSabrina LenobleZaher LakkisThierry NguyenSamuel LimatChristophe BorgMarine JaryStefano KimVirginie Nerichhttp://www.la-press.com/efficacy-safety-and-cost-of-regorafenib-in-patients-with-metastatic-co-article-a5743
collection DOAJ
language English
format Article
sources DOAJ
author Fabien Calcagno
Sabrina Lenoble
Zaher Lakkis
Thierry Nguyen
Samuel Limat
Christophe Borg
Marine Jary
Stefano Kim
Virginie Nerich
spellingShingle Fabien Calcagno
Sabrina Lenoble
Zaher Lakkis
Thierry Nguyen
Samuel Limat
Christophe Borg
Marine Jary
Stefano Kim
Virginie Nerich
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
Clinical Medicine Insights: Oncology
author_facet Fabien Calcagno
Sabrina Lenoble
Zaher Lakkis
Thierry Nguyen
Samuel Limat
Christophe Borg
Marine Jary
Stefano Kim
Virginie Nerich
author_sort Fabien Calcagno
title Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
title_short Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
title_full Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
title_fullStr Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
title_full_unstemmed Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
title_sort efficacy, safety and cost of regorafenib in patients with metastatic colorectal cancer in french clinical practice
publisher SAGE Publishing
series Clinical Medicine Insights: Oncology
issn 1179-5549
publishDate 2016-07-01
url http://www.la-press.com/efficacy-safety-and-cost-of-regorafenib-in-patients-with-metastatic-co-article-a5743
work_keys_str_mv AT fabiencalcagno efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT sabrinalenoble efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT zaherlakkis efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT thierrynguyen efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT samuellimat efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT christopheborg efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT marinejary efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT stefanokim efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
AT virginienerich efficacysafetyandcostofregorafenibinpatientswithmetastaticcolorectalcancerinfrenchclinicalpractice
_version_ 1724470752112017408

Similar Items